C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity

Synapse

Volumn 63, Issue 10, 2009, Pages 907-912

  Hirvonen, Mika M ^a,b   Laakso, Aki ^c   Någren, Kjell ^b   Rinne, Juha O ^b   Pohjalainen, Tiina ^a   Hietala, Jarmo ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Binding potential; Endophenotype; Neurotransmission; Positron emission tomography

Indexed keywords

ANKYRIN; DOPAMINE; DOPAMINE 2 RECEPTOR; MESSENGER RNA; RACLOPRIDE C 11; TAQ POLYMERASE;

ADULT; ALLELE; ARTICLE; DOPAMINE BLOOD LEVEL; FEMALE; GENOTYPE; HUMAN; IN VIVO STUDY; MALE; NEUROTRANSMISSION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RECEPTOR AFFINITY; RECEPTOR BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; STRIATE CORTEX; VOLUNTEER;

ADULT; AGED; ANALYSIS OF VARIANCE; CARBON ISOTOPES; CORPUS STRIATUM; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RACLOPRIDE; RECEPTORS, DOPAMINE D2; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 70349102541     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20672     Document Type: Article

References (44)

1. Abecasis GR, Cookson WO. 2000. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16:182-183.
2. Agnati LF, Ferre S, Lluis C, Franco R, Fuxe K. 2003. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 55:509-550. (Pubitemid 37013214)
3. Bannon MJ, Bunney EB, Roth RH. 1981. Mesocortical dopamine neurons: Rapid transmitter turnover compared to other brain catecholamine systems. Brain Res 218:376-382.
4. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH, Cohn JB. 1990. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263:2055-2060. (Pubitemid 20139952)
5. Cass WA, Gerhardt GA. 1995. In vivo assessment of dopamine uptake in rat medial prefrontal cortex: Comparison with dorsal striatum and nucleus accumbens. J Neurochem 65:201-207.
6. Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, Curtis C, Patte K, Hwang R, Kennedy JL. 2008. Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:620-628. (Pubitemid 351312353)
7. Doudet DJ, Holden JE. 2003. Sequential versus nonsequential measurement of density and affinity of dopamine D2 receptors with [11C]raclopride: Effect of methamphetamine. J Cereb Blood Flow Metab 23:1489-1494.
8. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV. 2003. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12:205-216. (Pubitemid 36204418)
9. Dubertret C, Gouya L, Hanoun N, Deybach JC, Ades J, Hamon M, Gorwood P. 2004. The 30 region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res 67:75-85. (Pubitemid 38117094)
10. Farde L, Hall H, Pauli S, Halldin C. 1995. Variability in D2-dopamine receptor density and affinity: A PET study with [11C]raclopride in man. Synapse 20:200-208.
11. Ferre S, Agnati LF, Ciruela F, Lluis C, Woods AS, Fuxe K, Franco R. 2007. Neurotransmitter receptor heteromers and their integrative role in "local modules": The striatal spine module. Brain Res Rev 55:55-67.
12. Fossella J, Green AE, Fan J. 2006. Evaluation of a structural polymorphism in the ankyrin repeat and kinase domain containing 1 (ANKK1) gene and the activation of executive attention networks. Cogn Affect Behav Neurosci 6:71-78. (Pubitemid 44237735)
13. Franco R, Casado V, Cortes A, Mallol J, Ciruela F, Ferre S, Lluis C, Canela EI. 2008. G-protein-coupled receptor heteromers: Function and ligand pharmacology. Br J Pharmacol 153 (Suppl 1):S90-S98. (Pubitemid 351340995)
14. Frank MJ, Moustafa AA, Haughey HM, Curran T, Hutchison KE. 2007. Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc Natl Acad Sci USA 104:16311-16316. (Pubitemid 350099356)
15. Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, Macrae AD, Torres GE, Kim KM, Lefkowitz RJ, Caron MG, Premont RT. 2003. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38:291-303. (Pubitemid 36555654)
16. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ, Kranzler HR, Farrer L. 2006. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet 15:3498-3507. (Pubitemid 44884117)
17. Hietala J, Syvalahti E, Vuorio K, Nagren K, Lehikoinen P, Ruotsalainen U, Rakkolainen V, Lehtinen V, Wegelius U. 1994a. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Arch Gen Psychiatry 51:116-123. (Pubitemid 24054313)
18. Hietala J, West C, Syvalahti E, Nagren K, Lehikoinen P, Sonninen P, Ruotsalainen U. 1994b. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 116:285-290. (Pubitemid 24345278)
19. Hietala J, Syvalahti E, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M, Solin O, Kuoppamaki M, Kirvela O, Ruotsalainen U. 1995. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 346:1130-1131.
20. Hietala J, Nagren K, Lehikoinen P, Ruotsalainen U, Syvalahti E. 1999. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: A test-retest analysis. J Cereb Blood Flow Metab 19:210-217. (Pubitemid 29284269)
21. Hill SY, Hoffman EK, Zezza N, Thalamuthu A, Weeks DE, Matthews AG, Mukhopadhyay I. 2008. Dopaminergic mutations: Within-family association and linkage in multiplex alcohol dependence families. Am J Med Genet B Neuropsychiatr Genet 147B:517-526. (Pubitemid 351830815)
22. Hirvonen M, Laakso A, Nagren K, Rinne JO, Pohjalainen T, Hietala J. 2004. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 9:1060-1061. (Pubitemid 40065447)
23. Hirvonen M, Laakso A, Någren K, Rinne JO, Pohjalainen T, Hietala J. 2005. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 10:889. (Corrigendum)
24. Hirvonen MM, Lumme V, Hirvonen J, Pesonen U, Någren K, Vahlberg T, Scheinin H, Hietala J. 2009. C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Prog Neuropsychopharmacol Biol Psychiatry, in press.
25. Jacobsen LK, Pugh KR, Mencl WE, Gelernter J. 2006. C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. Psychopharmacology 188:530-540. (Pubitemid 46766441)
26. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. 1999. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4:290-296. (Pubitemid 29292183)
27. Karoum F, Chrapusta SJ, Egan MF. 1994. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 63:972-979. (Pubitemid 24983998)
28. Laakso A, Pohjalainen T, Bergman J, Kajander J, Haaparanta M, Solin O, Syvalahti E, Hietala J. 2005. The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics 15:387-391. (Pubitemid 40835079)
29. Laruelle M. 1998. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med 42:211-221. (Pubitemid 28529874)
30. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 20:423-451. (Pubitemid 30164887)
31. Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann V, Restine S, Hawk L, Niaura R, Berrettini W. 2006. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: Results of two randomized clinical trials. Neuropsychopharmacology 31:231-242. (Pubitemid 43250960)
32. Monakhov M, Golimbet V, Abramova L, Kaleda V, Karpov V. 2008. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophr Res 100:302-307.
33. Neville MJ, Johnstone EC, Walton RT. 2004. Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23:540-545.
34. Noble EP. 2003. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet 116B:103-125. (Pubitemid 37063624)
35. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. 1991. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48:648-654.
36. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK, Hietala J. 1998a. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3:256-260. (Pubitemid 28266335)
37. Pohjalainen T, Rinne JO, Nagren K, Syvalahti E, Hietala J. 1998b. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am J Psychiatry 155:768-773. (Pubitemid 28252655)
38. Ponce G, Hoenicka J, Jimenez-Arriero MA, Rodriguez-Jimenez R, Aragues M, Martin-Sune N, Huertas E, Palomo T. 2008. DRD2 and ANKK1 genotype in alcohol-dependent patients with psychopathic traits: Association and interaction study. Br J Psychiatry 193:121-125.
39. Rodriguez-Jimenez R, Hoenicka J, Jimenez-Arriero MA, Ponce G, Bagney A, Aragues M, Palomo T. 2006. Performance in the Wisconsin Card Sorting Test and the C957T polymorphism of the DRD2 gene in healthy volunteers. Neuropsychobiology 54:166-170.
40. Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T. 2006. Psychosis pathways converge via D2high dopamine receptors. Synapse 60:319-346. (Pubitemid 44134353)
41. Slifstein M, Laruelle M. 2001. Models and methods for derivation of in vivo neuroreceptor parameters with PET and single photon emission computed tomography (SPECT) reversible radiotracers. Nucl Med Biol 28:595-608.
42. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. 1997. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7:479-484. (Pubitemid 27517576)
43. Xu H, Kellendonk CB, Simpson EH, Keilp JG, Bruder GE, Polan HJ, Kandel ER, Gilliam TC. 2007. DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability. Schizophr Res 90:104-107. (Pubitemid 46177561)
44. Zai CC, Hwang RW, De Luca V, Muller DJ, King N, Zai GC, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL. 2007. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients. Int J Neuropsychopharmacol 10:639-651. (Pubitemid 47517514)